{
    "id": 29476,
    "fullName": "FXR1 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FXR1-BRAF results from the fusion of FXR1 and BRAF, leading to increased Erk phosphorylation in culture (PMID: 29156677), and therefore, is predicted to lead to a gain of protein function. FXR1-BRAF has been identified in pediatric low-grade gliomas (PMID: 29156677).",
            "references": [
                {
                    "id": 14275,
                    "pubMedId": 29156677,
                    "title": "Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29156677"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8087,
        "geneSymbol": "FXR1",
        "terms": [
            "FXR1",
            "FXR1P"
        ]
    },
    "variant": "FXR1 - BRAF",
    "createDate": "02/25/2019",
    "updateDate": "02/25/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 31509,
            "profileName": "FXR1 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}